LoginRegister

    Monsanto India Q2 profit at Rs 24 cr, revenue up 33% at Rs 133.49 cr

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  
    Monsanto India Q2 profit at Rs 24 cr, revenue up 33% at Rs 133.49 cr




    New Delhi: Seed firm Monsanto India Monday reported a net profit of Rs 24.09 crore for the quarter ended September 2018. Its net loss stood at Rs 6.39 crore in the year-ago period, the company said in a regulatory filing.

    Total income rose to Rs 133.49 crore during July-September 2018 from Rs 100.22 crore in the corresponding period of the previous year, a rise of over 33 per cent.

    Global chemical and pharma major Bayer has acquired the US-based Monsanto globally for over USD 60 billion.






    BayerIndiaMonsantomonsanto indiaNew DelhiPharmaceutical industrySeed firmUSD
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X